If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspecs Group Regulatory News (SPEC)

Share Price Information for Inspecs Group (SPEC)

Share Price is delayed by 15 minutes
Get Live Data
97.00    0.00 (0.00%)
Bid:
94.00
Ask:
100.00
Spread: 6.00 (6.383%)
Market Cap: £105.90m
SPEC Live PriceLast checked at - London Stock Exchange

Intraday Inspecs Group Share Chart

Director/PDMR Share Dealing

24 Dec 2021 08:14

RNS Number : 7553W
Inspecs Group PLC
24 December 2021
 

24 December 2021

Inspecs Group Plc

("Inspecs" the "Company" or "Group")

 

Director/PDMR Share Dealing

 

On 23 December 2021, the following options to acquire Ordinary Shares of 1 pence each in the capital of the Company ("Ordinary Shares") were granted under the Inspecs Long Term Incentive Plan 2020 ("LTIP") to Robin Totterman and Chris Kay, the Chief Executive Officer and Chief Financial Officer respectively, of the Group. Each option entitled the optionholder to acquire 50,000 Ordinary Shares at an exercise price of 370 pence per Ordinary Share. The options vest on the 23 December 2024, being the third anniversary of grant, subject to the optionholder's continued employment with the Group.

 

1. Details of the person discharging managerial responsibilities/person closely associated

 

a) Name

Christopher Kay

2. Reason for the notification

 

a) Position/status

Chief Financial Officer

b) Initial notification / Amendment

Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Inspecs Group plc

b) LEI

2138008Z4S4DHR6NE933

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument

Ordinary Shares of 1 pence

b) Identification code

GB00BK6JPP03

c) Nature of the transaction

Grant of options over 50,000 ordinary shares with an exercise price of 370 pence per share under the Inspecs Long Term Incentive Plan

d) Price(s) and volume(s)

 

Price(s)

Volume(s)

 

370 pence

50,000

e) Aggregated information:

i. Aggregated volume

ii. price

N/A

f) Date of the transaction

23 December 2021

g) Place of the transaction

Outside a trading venue

 

 

1. Details of the person discharging managerial responsibilities/person closely associated

 

a) Name

Robin Totterman

2. Reason for the notification

 

a) Position/status

Chief Executive Officer

b) Initial notification / Amendment

Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Inspecs Group plc

b) LEI

2138008Z4S4DHR6NE933

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument

Ordinary Shares of 1 pence

b) Identification code

GB00BK6JPP03

c) Nature of the transaction

Grant of options over 50,000 ordinary shares with an exercise price of 370 pence per share under the Inspecs Long Term Incentive Plan

d) Price(s) and volume(s)

 

Price(s)

Volume(s)

 

370 pence

50,000

e) Aggregated information:

i. Aggregated volume

ii. price

N/A

f) Date of the transaction

23 December 2021

g) Place of the transaction

Outside a trading venue

 

 

For further information please contact:

 

Inspecs Group plc

Robin Totterman (CEO)

Chris Kay (CFO)

 

via FTI Consulting

Tel: +44 (0) 20 3727 1000

Peel Hunt (Nominated Adviser and Broker)

Adrian Trimmings

Andrew Clark

Will Bell

Tel: +44 (0) 20 7418 8900

 

FTI Consulting (Financial PR)

Alex Beagley

Alice Newlyn

Tel: +44 (0) 20 3727 1000

 

 

About Inspecs Group plc

 

Inspecs is a Bath-based designer, manufacturer and distributor of eyewear frames and optically advanced spectacle lenses. The Group produces a broad range of frames and lenses, covering optical, sunglasses and safety, which are either "Branded" (either under licence or under the Group's own proprietary brands), or "OEM" (including private label on behalf of retail customers and un-branded).

 

In December 2020, Inspecs acquired Eschenbach, a leading, global, eyewear supplier headquartered in Nuremberg, Germany, which includes the American company Tura. The acquisition extended the Group's presence internationally in key global markets. This followed the acquisition of lens maker Norville in July 2020, whereby Inspecs combined two heritage brands in British optical, Savile Row frame maker, and Norville lens maker, further enhancing its vertically integrated business model. As one of only a few companies that can offer this one-stop-shop solution to global retail chains, Inspecs is well positioned to continue to take market share in the globally expanding eyewear market.

 

Inspecs customers include global optical and non-optical retailers, global distributors and independent opticians, with its distribution network covering over 80 countries and reaching approximately 70,000 points of sale.

 

Inspecs has operations across the globe: with offices in the UK, Portugal, Scandinavia, the US and China (Hong Kong, Macau and Shenzhen), and manufacturing facilities in Vietnam, China, the UK and Italy. With the acquisition of Eschenbach, the Group's international reach further extends across Europe and the American markets.

 

The Group's growth strategy going forward is to: (i) continue to grow organically; (ii) undertake further acquisitions (and drive value through leveraging the Group's internal capabilities); and (iii) extend the Group's manufacturing capacity.

 

More information is available at: www.INSPECS.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFLTFVLSFIL
Date   Source Headline
10th Sep 20247:00 amRNSInterim Results
29th Aug 20241:15 pmRNSHolding(s) in Company
27th Aug 20247:00 amRNSNotice of Interim Results
12th Jul 20244:40 pmRNSHolding(s) in Company
12th Jun 20241:59 pmRNSHolding(s) in Company
6th Jun 20241:54 pmRNSResult of AGM
6th Jun 20247:00 amRNSAGM Statement
14th May 20241:49 pmRNSPosting of Annual Report and Notice of AGM
23rd Apr 20243:57 pmRNSHolding(s) in Company
19th Apr 20249:35 amRNSHolding(s) in Company
17th Apr 20247:00 amRNSFinal Results
29th Jan 20247:00 amRNSFull Year Trading Update
11th Jan 20242:10 pmRNSHolding(s) in Company
30th Oct 20237:00 amRNSTrading Update
20th Sep 202311:14 amRNSHolding(s) in Company
7th Sep 20237:00 amRNSInterim Results
28th Jul 20237:00 amRNSHalf Year Trading Update
15th Jun 20233:36 pmRNSResult of AGM
22nd May 20231:16 pmRNSNotice of AGM
3rd May 20232:42 pmRNSUpdate on Full Year Results
28th Apr 20231:36 pmRNSDirector/PDMR Share Dealing
27th Apr 20237:00 amRNSPreliminary Unaudited Results
19th Apr 202312:24 pmRNSHolding(s) in Company
23rd Mar 20237:00 amRNSHolding(s) in Company
14th Mar 20233:15 pmRNSHolding(s) in Company
30th Jan 20233:18 pmRNSHolding(s) in Company
27th Jan 20239:00 amRNSPrice Monitoring Extension
26th Jan 20239:05 amRNSSecond Price Monitoring Extn
26th Jan 20239:00 amRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSFull Year Trading Update
22nd Dec 20227:00 amRNSHolding(s) in Company
21st Dec 20227:00 amRNSHolding(s) in Company
19th Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20227:00 amRNSAppointment of Non-Executive Directors
25th Nov 20224:41 pmRNSSecond Price Monitoring Extn
25th Nov 20224:35 pmRNSPrice Monitoring Extension
11th Nov 202211:05 amRNSSecond Price Monitoring Extn
11th Nov 202211:00 amRNSPrice Monitoring Extension
9th Nov 20223:33 pmRNSHolding(s) in Company
8th Nov 20222:06 pmRNSSecond Price Monitoring Extn
8th Nov 20222:00 pmRNSPrice Monitoring Extension
8th Nov 20227:00 amRNSDirector/PDMR Share Dealing
3rd Nov 20227:00 amRNSDirector/PDMR Share Dealing
31st Oct 20223:05 pmRNSDirector/PDMR Shareholding
28th Oct 20226:25 pmRNSDirector/PDMR Shareholding - Replacement
28th Oct 20223:25 pmRNSDirector/PDMR Shareholding
27th Oct 20222:06 pmRNSSecond Price Monitoring Extn
27th Oct 20222:00 pmRNSPrice Monitoring Extension
27th Oct 20229:05 amRNSSecond Price Monitoring Extn
27th Oct 20229:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.